Ontology highlight
ABSTRACT:
SUBMITTER: Kirubhanand C
PROVIDER: S-EPMC7452744 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Bioinformation 20200630 6
The Bcl-2 protein is liked in several cancers and drug resistance to therapy is also known in this context. There are many Bcl-2 inhibitors under clinical trials. It is of further interest to design new Bcl2 inhibitors from phyto compounds such as artesunate, bruceantin, maytansin, Salvicine, indicine N-oxide, kamebanin and oxyacanthine. We report the optimal binding features of these compounds with Bcl-2 for further consideration towards in vitro and in vivo validation. ...[more]